lidoflazine has been researched along with Hypokalemia in 2 studies
Lidoflazine: Coronary vasodilator with some antiarrhythmic action.
Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carmeliet, E | 1 |
| Xhonneux, R | 1 |
| Reneman, RS | 1 |
| Lehmann, HU | 1 |
| Scholle, J | 1 |
| Hochrein, H | 1 |
2 other studies available for lidoflazine and Hypokalemia
| Article | Year |
|---|---|
Lidoplazine and Na and K distribution in normo-and hypokalaemic rats.
Topics: Animals; Body Water; Body Weight; Diaphragm; Erythrocytes; Extracellular Space; Heart; Heart Atria; | 1975 |
[The effect of lidoflazine on the excitation process in the resting and stress ECG in coronary patients (author's transl)].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Coronary Disease; | 1974 |